Clinical Effectiveness of Intravitreal Fluocinolone Acetonide (FAc) (ILUVIEN™) in Patients with Diabetic Macular Oedema (DMO) Refractory to Prior Therapy: The Manchester Experience
Sign Up to like & getrecommendations! Published in 2019 at "Ophthalmology and Therapy"
DOI: 10.1007/s40123-019-0197-3
Abstract: IntroductionDiabetic macular oedema (DMO) remains a significant cause of sight loss in the UK. Despite macular laser and anti-VEGF agents, a large proportion of patients remain with persistent DMO. We present our results of using… read more here.
Keywords: acetonide fac; year; fluocinolone acetonide; macular oedema ... See more keywords
Bilateral 0.19 mg Fluocinolone Acetonide Intravitreal Implant in the Successful Treatment of Juvenile Idiopathic Arthritis-Associated Uveitis and Secondary Macular Oedema: A Case Report and Review of Intravitreal Therapies
Sign Up to like & getrecommendations! Published in 2021 at "Ophthalmology and Therapy"
DOI: 10.1007/s40123-020-00328-9
Abstract: Introduction Treatment of juvenile idiopathic arthritis (JIA)-associated uveitis necessitates the use of long-term corticosteroids or immunosuppressive agents, each of which poses their own significant side effect profile. Initial treatment requires intensive topical glucocorticoids, with a… read more here.
Keywords: associated uveitis; treatment; macular oedema; fluocinolone acetonide ... See more keywords
Fluocinolone Acetonide Intravitreal Implant 0.19 mg (ILUVIEN®): A Review in Diabetic Macular Edema
Sign Up to like & getrecommendations! Published in 2017 at "Drugs"
DOI: 10.1007/s40265-017-0722-4
Abstract: Fluocinolone acetonide intravitreal implant 0.19 mg (ILUVIEN®) is a nonbiodegradable, injectable, corticosteroid implant that is approved in several countries, including the USA, for the treatment of diabetic macular edema (DME). ILUVIEN® releases fluocinolone acetonide at an… read more here.
Keywords: acetonide intravitreal; implant iluvien; fluocinolone acetonide; intravitreal implant ... See more keywords
Fluocinolone Acetonide Intravitreal Implant for Treating Recurrent Non-infectious Uveitis: An Evidence Review Group Perspective of a NICE Single Technology Appraisal
Sign Up to like & getrecommendations! Published in 2019 at "Pharmacoeconomics"
DOI: 10.1007/s40273-019-00851-z
Abstract: The National Institute for Health and Care Excellence (NICE) invited Alimera Sciences, the company manufacturing fluocinolone acetonide intravitreal implant (FAc) 0.19 mg (tradename ILUVIEN ® ), to submit evidence on the clinical and cost-effectiveness of FAc… read more here.
Keywords: company; intravitreal implant; fluocinolone acetonide; evidence ... See more keywords
Long-term Effects of Intravitreal 0.19 mg Fluocinolone Acetonide Implant on Progression and Regression of Diabetic Retinopathy.
Sign Up to like & getrecommendations! Published in 2017 at "Ophthalmology"
DOI: 10.1016/j.ophtha.2016.11.034
Abstract: OBJECTIVE To investigate the effects of fluocinolone acetonide (FAc) on the progression to proliferative diabetic retinopathy (PDR) and the impact of FAc on changes in Early Treatment Diabetic Retinopathy Study (ETDRS) diabetic retinopathy (DR) severity… read more here.
Keywords: diabetic retinopathy; pdr; fluocinolone acetonide; progression ... See more keywords
Real-world experience with 0.2 μg/day fluocinolone acetonide intravitreal implant (ILUVIEN) in the United Kingdom
Sign Up to like & getrecommendations! Published in 2017 at "Eye"
DOI: 10.1038/eye.2017.125
Abstract: AimsTo compare safety outcomes and visual function data acquired in the real-world setting with FAME study results in eyes treated with 0.2 μg/day fluocinolone acetonide (FAc).MethodsFourteen UK clinical sites contributed to pseudoanonymised data collected using the… read more here.
Keywords: real world; fluocinolone acetonide; day fluocinolone; iop ... See more keywords
Evaluation of the clinical effectiveness in routine practice of fluocinolone acetonide 190 µg intravitreal implant in people with diabetic macular edema
Sign Up to like & getrecommendations! Published in 2017 at "Current Medical Research and Opinion"
DOI: 10.1080/03007995.2017.1366645
Abstract: Abstract Objective: The aim of the Iluvien Clinical Evidence study in the UK (ICE-UK) was to assess the real-world effectiveness of fluocinolone acetonide (FAc) 190 µg intravitreal implant for the treatment of clinically significant chronic diabetic… read more here.
Keywords: 190 intravitreal; intravitreal implant; diabetic macular; fluocinolone acetonide ... See more keywords
Health-economic evaluation of fluocinolone acetonide 190 µg implant in people with diabetic macular edema
Sign Up to like & getrecommendations! Published in 2017 at "Current Medical Research and Opinion"
DOI: 10.1080/03007995.2017.1366663
Abstract: Abstract Objectives: To assess healthcare resource use and costs of treating people with clinically significant diabetic macular edema (DME) with fluocinolone acetonide (FAc) 190 µg intravitreal implant in routine clinical practice. Methods: The retrospective Iluvien… read more here.
Keywords: fac implant; fluocinolone acetonide; diabetic macular; macular edema ... See more keywords
Indicators of Post-Operative Intraocular Pressure Elevation after Naïve Fluocinolone Acetonide Surgical Implantation
Sign Up to like & getrecommendations! Published in 2019 at "Ocular Immunology and Inflammation"
DOI: 10.1080/09273948.2019.1624778
Abstract: ABSTRACT Purpose To determine factors conferring an increased risk of developing ocular hypertension secondary to the fluocinolone acetonide (FA) sustained-release surgical implant (Retisert). Design Retrospective, observational case series. Methods Patients with a history of chronic… read more here.
Keywords: indicators post; fluocinolone acetonide; implantation; risk factor ... See more keywords
Comparing the Efficacy of Intravitreal Dexamethasone and Time-displaced Fluocinolone Acetonide on Central Retinal Thickness in Patients with Uveitis
Sign Up to like & getrecommendations! Published in 2022 at "Ocular Immunology and Inflammation"
DOI: 10.1080/09273948.2021.2018469
Abstract: ABSTRACT Background To compare the efficacy of intravitreally administered dexamethasone (Dex) and subsequent time-displaced fluocinolone acetonide (FA) on central subfield thickness (CST) in eyes with noninfectious uveitis. Methods Retrospective analysis of twenty-three eyes (18 patients)… read more here.
Keywords: acetonide central; fluocinolone acetonide; displaced fluocinolone; dex ... See more keywords
Efficacy of the Fluocinolone Acetonide (Yutiq) Intravitreal Implant as Monotherapy for Uveitis.
Sign Up to like & getrecommendations! Published in 2022 at "Ocular immunology and inflammation"
DOI: 10.1080/09273948.2022.2076131
Abstract: PURPOSE To evaluate the efficacy of the fluocinolone acetonide intravitreal implant (Yutiq) as monotherapy for uveitis. DESIGN Retrospective cohort study. PARTICIPANTS Patients at a single academic health-care institution. METHODS Medical record review of patients with… read more here.
Keywords: uveitis; intravitreal implant; fluocinolone acetonide; efficacy fluocinolone ... See more keywords